Study to Investigate Safety, Tolerability, Pharmacokinetics, and Drug-drug Interaction of Multiple Oral Doses of BAY1830839 in Healthy Male Participants
Clinical trial NCT03965728 · COMPLETED
Trial details
- NCT number
- NCT03965728
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-05
- Primary completion
- 2022-01-21
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.